[go: up one dir, main page]

SK279136B6 - Hydrazóny, farmaceutické prípravky s ich obsahom a - Google Patents

Hydrazóny, farmaceutické prípravky s ich obsahom a Download PDF

Info

Publication number
SK279136B6
SK279136B6 SK1317-91A SK131791A SK279136B6 SK 279136 B6 SK279136 B6 SK 279136B6 SK 131791 A SK131791 A SK 131791A SK 279136 B6 SK279136 B6 SK 279136B6
Authority
SK
Slovakia
Prior art keywords
group
formula
compounds
pharmaceutically acceptable
hydrogen atom
Prior art date
Application number
SK1317-91A
Other languages
English (en)
Slovak (sk)
Inventor
Jaroslav Stanek
J�rg FREI
Giorgio Caravatti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK279136B6 publication Critical patent/SK279136B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C337/00Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C337/06Compounds containing any of the groups, e.g. thiosemicarbazides
    • C07C337/08Compounds containing any of the groups, e.g. thiosemicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. thiosemicarbazones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10Hydrazines
    • C07C243/20Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06Compounds containing any of the groups, e.g. semicarbazides
    • C07C281/08Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
    • C07C281/12Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones the carbon atom being part of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Photolithography (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Wire Bonding (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1317-91A 1990-05-07 1991-05-06 Hydrazóny, farmaceutické prípravky s ich obsahom a SK279136B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH153890 1990-05-07

Publications (1)

Publication Number Publication Date
SK279136B6 true SK279136B6 (sk) 1998-07-08

Family

ID=4212764

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1317-91A SK279136B6 (sk) 1990-05-07 1991-05-06 Hydrazóny, farmaceutické prípravky s ich obsahom a

Country Status (26)

Country Link
EP (1) EP0456133B1 (sv)
JP (1) JP2565602B2 (sv)
KR (1) KR100203234B1 (sv)
AT (1) ATE119878T1 (sv)
AU (1) AU645799B2 (sv)
CA (1) CA2041832C (sv)
CY (1) CY2080B1 (sv)
CZ (1) CZ279340B6 (sv)
DE (1) DE59104930D1 (sv)
DK (1) DK0456133T3 (sv)
ES (1) ES2069768T3 (sv)
FI (1) FI107916B (sv)
GR (1) GR3015574T3 (sv)
HK (1) HK1000919A1 (sv)
HU (1) HU218221B (sv)
ID (1) ID1040B (sv)
IE (1) IE66157B1 (sv)
IL (1) IL98008A (sv)
NO (1) NO175097C (sv)
NZ (1) NZ238033A (sv)
PT (1) PT97571B (sv)
RU (2) RU2057748C1 (sv)
SA (1) SA91120283B1 (sv)
SK (1) SK279136B6 (sv)
TW (1) TW202428B (sv)
ZA (1) ZA913391B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395855A (en) * 1990-05-07 1995-03-07 Ciba-Geigy Corporation Hydrazones
RU2081108C1 (ru) * 1991-10-16 1997-06-10 Циба-Гейги АГ Аддитивные соли кислот с основанием и фармацевтическая композиция, обладающая противоопухолевой активностью
WO1993020046A1 (fr) * 1992-04-03 1993-10-14 Innothera Derives d'indane-1,3-dione et d'indane-1,2,3-trione, leurs procedes de preparation et leur application en therapeutique
ES2103166B1 (es) * 1992-08-26 1998-04-01 Ciba Geigy Ag Procedimiento para la obtencion de amidinohidrazonas biciclicas.
FR2710639B1 (fr) * 1993-10-01 1995-12-22 Innothera Lab Sa Dérivés d'indane cétoniques, leur procédé d'obtention, leur application thérapeutique.
JP3989543B2 (ja) * 1995-01-26 2007-10-10 ノバルティス・アクチエンゲゼルシャフト イミダゾール誘導体、その製造およびs−アデノシルメチオニンデカルボキシラーゼ(=samdc)阻害剤としてのその使用
EP1408028A1 (en) * 2002-10-09 2004-04-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection
EP1834669A1 (en) * 2006-03-15 2007-09-19 Heinrich-Pette-Institut Use of specific hydrazone compounds for the treatment of viral infections
EP1884515A1 (en) * 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
CN102627593A (zh) * 2012-02-23 2012-08-08 河南师范大学 具有抗癌活性的1,4-二羟基-2-甲酰基-9,10蒽醌缩氨硫脲新化合物及制备方法
WO2016001390A1 (en) * 2014-07-02 2016-01-07 Inflectis Bioscience O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated an accumulation of misfolded proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7407469A (nl) * 1974-06-01 1975-12-03 Akzo Nv Nieuwe amidinohydrazonverbindingen.
DE3416695A1 (de) * 1984-05-05 1985-11-07 Bayer Ag, 5090 Leverkusen Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE68913706T2 (de) * 1988-12-27 1994-08-04 Du Pont Substituierte Semicarbazon-Arthropodizide.

Also Published As

Publication number Publication date
AU7596791A (en) 1991-11-07
NO911777L (no) 1991-11-08
IL98008A0 (en) 1992-06-21
KR100203234B1 (ko) 1999-06-15
RU2057748C1 (ru) 1996-04-10
HUT57183A (en) 1991-11-28
PT97571A (pt) 1992-01-31
IE911530A1 (en) 1991-11-20
EP0456133B1 (de) 1995-03-15
AU645799B2 (en) 1994-01-27
TW202428B (sv) 1993-03-21
ATE119878T1 (de) 1995-04-15
NO911777D0 (no) 1991-05-06
HU218221B (hu) 2000-06-28
DE59104930D1 (de) 1995-04-20
GR3015574T3 (en) 1995-06-30
RU2066311C1 (ru) 1996-09-10
CZ279340B6 (cs) 1995-04-12
NO175097C (no) 1994-08-31
FI107916B (sv) 2001-10-31
JP2565602B2 (ja) 1996-12-18
FI912164A (fi) 1991-11-08
FI912164A0 (fi) 1991-05-03
NO175097B (no) 1994-05-24
SA91120283B1 (ar) 2005-12-17
EP0456133A1 (de) 1991-11-13
CA2041832C (en) 2002-09-17
KR910019964A (ko) 1991-12-19
HK1000919A1 (en) 1998-05-08
PT97571B (pt) 1999-04-30
JPH04225946A (ja) 1992-08-14
CS131791A3 (en) 1992-03-18
ZA913391B (en) 1991-12-24
CA2041832A1 (en) 1991-11-08
ES2069768T3 (es) 1995-05-16
NZ238033A (en) 1993-01-27
CY2080B1 (en) 1998-10-16
ID1040B (id) 1996-10-25
DK0456133T3 (da) 1995-05-22
IE66157B1 (en) 1995-12-13
IL98008A (en) 1996-08-04

Similar Documents

Publication Publication Date Title
RU2174844C2 (ru) Комбинация ингибиторов no-синтетазы и улавливателей реакционноспособных форм кислорода
WO2015054197A1 (en) Hdac inhibitors, alone or in combination with btk inhibitors, for treating non-hodgkin's lymphoma
SK63294A3 (en) Organic salts of n,n'-diacetylcystine
SK279136B6 (sk) Hydrazóny, farmaceutické prípravky s ich obsahom a
US4452800A (en) Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
CN106957315B (zh) N-取代苯磺酰基-氮杂吲哚氧基苯甲酰胺类化合物及其制备药物的用途
IL99237A (en) Preparation of a preparation in the form of a tablet or pill containing a compound sensitive to moisture, heat and light with a monoclinic crystal structure
SK15499A3 (en) Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
WO1989005637A1 (en) Improving toxicity profiles in chemotherapy
JP2515119B2 (ja) ピペラジン誘導体を含有する活性酸素産生抑制ならびに活性酸素除去作用を有する医薬組成物
US4861784A (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
EP0617959A1 (en) Pharmaceutical for the treatment of skin disorders
US4148879A (en) Inhibition of platelet aggregation with selected phosphonic and phosphinic acid esters
US4148878A (en) Inhibition of platelet aggregation with selected phosphoric acid esters
US5885993A (en) Remedy for pancreatitis
US3701829A (en) Treatment of parkinson's disease
US3714363A (en) Substituted amino guanidine as anti-diabetic agents
US5886000A (en) Anti-HIV agent
NZ235914A (en) Immunosuppressant pharmaceutical composition
WO1991008668A1 (en) Inhibitors of pneumocystis carinii dihydrofolate reductase
CZ281691B6 (cs) Farmaceutický prostředek proti vysokému krevnímu tlaku
JPH0641408B2 (ja) 酵素阻害剤
US3821381A (en) Method of treatment
CA2377686C (en) Mercaptoacylcysteine derivatives as therapeutic agents for osteoarthritis
US3821409A (en) Method of treatment

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100506